SRZN: DUET study launches this year to test dual VEGF/Wnt therapy in DME, targeting clinical differentiation
The DUET clinical study will launch later this year, evaluating a dual VEGF/Wnt molecule in DME with Vabysmo as comparator, focusing on safety, durability, and unique reperfusion endpoints. Strong preclinical data, robust IP, and upcoming milestones—including IND clearance and new financing—positio…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.